A stochastic spatial model of HIV dynamics with an asymmetric battle between the virus and the immune system

A stochastic spatial model based on the Monte Carlo approach is developed to study the dynamics of human immunodeficiency virus (HIV) infection. We aim to propose a more detailed and realistic simulation frame by incorporating many important features of HIV dynamics, which include infections, replications and mutations of viruses, antigen recognitions, activations and proliferations of lymphocytes, and diffusions, encounters and interactions of virions and lymphocytes. Our model successfully reproduces the three-phase pattern observed in HIV infection, and the simulation results for the time distribution from infection to AIDS onset are also in good agreement with the clinical data. The interactions of viruses and the immune system in all the three phases are investigated. We assess the relative importance of various immune system components in the acute phase. The dynamics of how the two important factors, namely the viral diversity and the asymmetric battle between HIV and the immune system, result in AIDS are investigated in detail with the model.

[1]  B. Walker,et al.  The great escape – AIDS viruses and immune control , 1999, Nature Medicine.

[2]  C. Dye,et al.  HIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populations. , 2006, The Journal of infectious diseases.

[3]  Alan S. Perelson,et al.  Characterizing T Cell Movement within Lymph Nodes in the Absence of Antigen1 , 2007, The Journal of Immunology.

[4]  M A Nowak,et al.  The evolutionary dynamics of HIV-1 quasispecies and the development of immunodeficiency disease. , 1990, AIDS.

[5]  Roel A. Coutinho,et al.  Time from HIV-1 seroconversion to Aids and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis: collaborative Group on Aids incubation and HIV survival including the CASCADE EU concerted action , 2000 .

[6]  K. F. Tipton,et al.  Biochemical systems analysis: A study of function and design in molecular biology , 1978 .

[7]  B. Haynes,et al.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. , 1984, Science.

[8]  B. Stockinger,et al.  Following the development of a CD4 T cell response in vivo: from activation to memory formation. , 1999, Immunity.

[9]  J. Mcghee,et al.  HIV infection: first battle decides the war. , 2006, Trends in immunology.

[10]  Z. Grossman,et al.  HIV preferentially infects HIV-specific CD4+ T cells , 2002, Nature.

[11]  M. Savageau.  Biochemical Systems Analysis: A Study of Function and Design in Molecular Biology , 1976 .

[12]  Herbert Levine,et al.  Comment on "dynamics of HIV infection: a cellular automata approach". , 2002, Physical review letters.

[13]  Philip J. R. Goulder,et al.  HIV and SIV CTL escape: implications for vaccine design , 2004, Nature Reviews Immunology.

[14]  Stephen C. Jameson,et al.  Maintaining the norm: T-cell homeostasis , 2002, Nature Reviews Immunology.

[15]  Alan S. Perelson,et al.  Turnover Rates of B Cells, T Cells, and NK Cells in Simian Immunodeficiency Virus-Infected and Uninfected Rhesus Macaques1 , 2003, The Journal of Immunology.

[16]  Ian A Wilson,et al.  The specificity of TCR/pMHC interaction. , 2002, Current opinion in immunology.

[17]  Christian L. Althaus,et al.  Dynamics of Immune Escape during HIV/SIV Infection , 2008, PLoS Comput. Biol..

[18]  G. Shaw,et al.  Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.

[19]  P. Allen,et al.  Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands , 1996, The Journal of experimental medicine.

[20]  S. Rowland-Jones,et al.  Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection , 2000, AIDS.

[21]  J. Levy,et al.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. , 1984, Science.

[22]  J. Chermann,et al.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). , 1983, Science.

[23]  C. Janeway,et al.  Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Henrique Veiga-Fernandes,et al.  Response of naïve and memory CD8+ T cells to antigen stimulation in vivo , 2000, Nature Immunology.

[25]  Martin Meier-Schellersheim,et al.  Pathogenesis of HIV infection: what the virus spares is as important as what it destroys , 2006, Nature Medicine.

[26]  R. Doms.  Beyond receptor expression: the influence of receptor conformation, density, and affinity in HIV-1 infection. , 2000, Virology.

[27]  T. Watts,et al.  Biophysical aspects of antigen recognition by T cells. , 1987, Annual review of immunology.

[28]  K. Rock,et al.  Antigen processing and presentation by the class I major histocompatibility complex. , 1996, Annual review of immunology.

[29]  W. S. Hlavacek,et al.  Mathematical and computational models of immune-receptor signalling , 2004, Nature Reviews Immunology.

[30]  Alan S Perelson,et al.  HIV dynamics with multiple infections of target cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[31]  David Heckerman,et al.  Phylogenetic Dependency Networks: Inferring Patterns of CTL Escape and Codon Covariation in HIV-1 Gag , 2008, PLoS Comput. Biol..

[32]  Dominik Wodarz,et al.  Killer cell dynamics : mathematical and computational approaches to immunology , 2007 .

[33]  D. Richman,et al.  Rapid evolution of the neutralizing antibody response to HIV type 1 infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Abdessamad Tridane,et al.  A viral load-based cellular automata approach to modeling HIV dynamics and drug treatment. , 2008, Journal of theoretical biology.

[35]  R. M. Zorzenon dos Santos,et al.  Dynamics of HIV infection: a cellular automata approach. , 2001, Physical review letters.

[36]  M. Bevan.  Helping the CD8+ T-cell response , 2004, Nature Reviews Immunology.

[37]  Alan S. Perelson.  Virus Dynamics: Mathematical Principles of Immunology and Virology, Martin A. Nowak, Robert M. May. Oxford University Press, Oxford, 2000. $34.95 (paper), $70 (hardcover) , 2001 .

[38]  L. M. Mansky,et al.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase , 1995, Journal of virology.

[39]  T. Reichenbach,et al.  Mobility promotes and jeopardizes biodiversity in rock–paper–scissors games , 2007, Nature.

[40]  D. Ho,et al.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.

[41]  D. Richman,et al.  Spatiotemporal dynamics of HIV propagation. , 2002, Journal of theoretical biology.

[42]  J. Coffin,et al.  HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy , 1995, Science.

[43]  K. Smith,et al.  Th1 and Th2 CD4+ T Cells Provide Help for B Cell Clonal Expansion and Antibody Synthesis in a Similar Manner In Vivo1 , 2000, The Journal of Immunology.

[44]  R. Hayes,et al.  Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV‐infected adults in Abidjan, Côte d'Ivoire , 1997, AIDS.

[45]  E. Ingulli,et al.  Visualization of specific B and T lymphocyte interactions in the lymph node. , 1998, Science.

[46]  A. Fauci,et al.  The immunopathogenesis of human immunodeficiency virus infection. , 1993, The New England journal of medicine.

[47]  Brian Dangerfield,et al.  Optimisation as a statistical estimation tool: an example in estimating the AIDS treatment‐free incubation period distribution , 1999 .

[48]  M. Greaves,et al.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus , 1984, Nature.

[49]  R. Koup,et al.  Preferential Infection Shortens the Life Span of Human ImmunodeficiencyVirus-Specific CD4+ T Cells In Vivo , 2006, Journal of Virology.

[50]  M A Nowak,et al.  Antigenic diversity thresholds and the development of AIDS. , 1991, Science.

[51]  K. Rock.  A new foreign policy: MHC class I molecules monitor the outside world. , 1996, Immunology today.

[52]  D. Douek,et al.  HIV disease: fallout from a mucosal catastrophe? , 2006, Nature Immunology.

[53]  Alan S. Perelson,et al.  Decay characteristics of HIV-1-infected compartments during combination therapy , 1997, Nature.

[54]  Hiv Survival,et al.  Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis , 2000, The Lancet.

[55]  Mark M. Davis,et al.  T-cell antigen receptor genes and T-cell recognition , 1988, Nature.

[56]  M. Bevan,et al.  Introduction of soluble protein into the class I pathway of antigen processing and presentation , 1988, Cell.

[57]  S. Bornholdt,et al.  From HIV infection to AIDS: a dynamically induced percolation transition? , 2002, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[58]  D. Dimitrov,et al.  Cell Biology of Virus Entry , 2000, Cell.

[59]  Michael W Deem,et al.  Physical theory of the competition that allows HIV to escape from the immune system. , 2006, Physical review letters.

[60]  G. Shaw,et al.  Dynamics of HIV-1 recombination in its natural target cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[61]  M. Nowak.  HIV mutation rate , 1990, Nature.

[62]  S Oehen,et al.  Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. , 1998, Journal of immunology.

[63]  D. Parker.  T cell-dependent B cell activation. , 1993, Annual review of immunology.

[64]  R. Pomerantz,et al.  Twenty years of therapy for HIV-1 infection , 2003, Nature Medicine.

[65]  Rob J. De Boer,et al.  Estimating Costs and Benefits of CTL Escape Mutations in SIV/HIV Infection , 2006, PLoS Comput. Biol..

[66]  Brian G. Williams,et al.  Antiretroviral Drugs for Tuberculosis Control in the Era of HIV/AIDS , 2003, Science.

[67]  Andrew N. Phillips,et al.  Reduction of HIV Concentration During Acute Infection: Independence from a Specific Immune Response , 1996, Science.